Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001681:Biological Assay; D002247:Carbon Isotopes; D003561:Cytarabine / Q000008:administration & dosage* / Q000097:blood / Q000494:pharmacology; D004357:Drug Synergism; D013293:Enterococcus faecalis / Q000187:drug effects; D005260:Female; D005663:Furans / Q000008:administration & dosage*; D006801:Humans; D007274:Injections, Intraperitoneal; D007939:Leukemia L1210 / Q000188:drug therapy*; D051379:Mice; D009705:Nucleosides / Q000008:administration & dosage*; D014529:Uridine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D005663:Furans; D009705:Nucleosides; D003561:Cytarabine; D014529:Uridine